Navigation Links
Valeant Pharmaceuticals to Announce 2012 First Quarter Results on May 3, 2012
Date:4/16/2012

MONTREAL, April 16, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Thursday, May 3, 2012 at 10:00 a.m. ET (7:00 a.m. PT) to discuss results for the 2012 first quarter.

The dial-in number to participate on this call is (877) 876-8393, confirmation code 70937718. International callers should dial (973) 200-3961, confirmation code 70937718. A replay will be available approximately two hours following the conclusion of the conference call to Thursday, May 10, 2012, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 70937718.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at www.valeant.com.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com.

(Logo:  http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- A decade-long JDRF-funded study led by the Institute ... Germany , is providing a deeper understanding of ... type 1 diabetes (T1D), highlighting the importance of pre-diabetes ... "Seroconversion to Multiple Islet Autoantibodies and Risk of Progression ... The Journal of the American Medical Association . ...
(Date:6/19/2013)... LARKSPUR, Calif. , June 19, 2013 /PRNewswire/ ... to improve sample standardization and handling in many ... the issuance of new patents by the U.S. ... company,s thermo-conductive products developed to standardize sample handling ... accuracy of results in common laboratory procedures. ...
(Date:6/19/2013)... Md. , June 19, 2013 /PRNewswire/ -- Chindex ... an American healthcare company providing services in ... United Family Healthcare, a network of private hospitals ... opening of its Beijing United Family Rehabilitation Hospital ... projects of the United Family Healthcare ("UFH") network. ...
Breaking Medicine Technology:New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5
... Ind., Nov. 1, 2010 Hill-Rom (NYSE: ... as Senior Vice President and Chief Financial Officer. Guinan ... and will officially join Hill-Rom on December 13, 2010. ... & Johnson, Guinan held a number of senior financial ...
... Romark Laboratories announced that data ... being presented at the 61st Annual Meeting of ... Diseases (AASLD), also known as The Liver Meeting® ... (Logo: http://www.newscom.com/cgi-bin/prnh/20100201/FL47022LOGO) (Logo: ...
Cached Medicine Technology:Hill-Rom Appoints Mark Guinan as Chief Financial Officer 2Romark Announces Data Presented at AASLD Meeting 2010 2Romark Announces Data Presented at AASLD Meeting 2010 3Romark Announces Data Presented at AASLD Meeting 2010 4Romark Announces Data Presented at AASLD Meeting 2010 5
(Date:6/19/2013)... Leading Japanese pharmaceutical companies, along with the Japanese ... pledged their commitment to bolster Japan,s contribution to ... Fund (GHIT Fund), at a press conference held ... International Conference on African Development (TICAD V). , ... the Ministry of Health, Labour and Welfare, the ...
(Date:6/19/2013)... 19, 2013 Dental professionals are increasingly ... from minor to moderate sedation, a patient’s breathing depth ... Dentistry is the latest to update its guidelines to ... sedation in an effort to increase safety in procedures. ... Practice Act goes into effect July 1. , ...
(Date:6/19/2013)... 19, 2013 PREFERRED Therapy Providers, Inc. ... Arizona to offer a new Medicare Advantage Plan ... Paz, Yavapai and Mohave, Arizona counties. The agreement takes ... effective January 1, 2013 and Maricopa and Pima counties ... Inc., the parent company of WellCare of Arizona has ...
(Date:6/19/2013)... Brightree LLC , the leading provider of cloud-based ... care industry, has been ranked for the first time - ... (HCI 100) list. This prestigious list features the top ... revenue during the last fiscal year. Since 2005, Brightree’s revenue ... the company has built its organization to more than 500 ...
(Date:6/19/2013)... Scottsdale, AZ (PRWEB) June 19, 2013 Guests ... feel healthy, wealthy and wise even if they don’t go ... that does require some early thought. , ... pockets when they take advantage of the pet-friendly Scottsdale Paradise ... Percent Package . With at least 14 days advance notice, ...
Breaking Medicine News(10 mins):Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 2Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 3Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 2Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 3Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 2Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 4
... COM , , VANCOUVER, Nov. ... COM) today disclosed that its Chairman and Chief Executive Officer, ... 45,000 common shares from his direct holding of Cardiome stock. ... to have been required to involuntarily sell any shares of ...
... the danger is about the same as using drugs ... News) -- Giving blood transfusions to treat anemia in ... clots, say University of Rochester, N.Y., researchers. , But ... cancer treatment-related anemia, the scientists said, after having analyzed ...
... Antonio Banderas launched his fifth,fragrance, BLUE SEDUCTION FOR ... City alongside cast members from Tony Award(R) Winning Best ... of the Roses, Ballet,Hispanico School of Dance, R. Evolucion ... (See video from PUIG USA at:, ...
... Nov. 28 Streamline Health Solutions,Inc. (Nasdaq: STRM ... quarter of fiscal year 2008 ended October 31, 2008 on ... and webcast to discuss,the results on Monday, December 15, at ... conference call to provide additional time for,completion of the necessary ...
... understanding of the disease generally, researchers say , , FRIDAY, ... people with the rarer, inherited form of Alzheimer,s disease ... understand the biology of the brain disorder. , ... a known genetic mutation causing the rare, early-onset form ...
... With new HIV infections outpacing the,number of people newly ... this World AIDS Day to call for a global commitment ... take place,on December 1st, in Washington, D.C., will be followed ... Given the recent election, the world is hopeful that ...
Cached Medicine News:Health News:Cardiome Discloses Chairman And CEO's Involuntary Share Sale 2Health News:Cardiome Discloses Chairman And CEO's Involuntary Share Sale 3Health News:Transfusing Anemic Cancer Patients Boosts Clot Risk 2Health News:Streamline Health Reschedules Q3 Financial Results Release and Conference Call for Monday, December 15, 2008 2Health News:Study Recruiting From Alzheimer's-Prone Families 2Health News:Faith and Civil Society Leaders Hold Interfaith Service to Commemorate World AIDS Day 2
... The Magnetom C! system features 270 accessibility ... with the smallest pole diameter available (54 ... of up to four coils, increased patient ... field strength is 0.35 Tesla. , ,The ...
... Quality of Vision and Contrast Sensitivity. ... illumination and glare luminance levels for ... testing with/without glare and background luminance ... ANSI standards. All Light Levels Microprocessor ...
The generously sized STERILE VIEW Monk Hood from DePuy provides splash protection in the chin and neck areas from body fluids and liquids. Shoulder cut outs and ties ensure a comfortable fit. This pr...
STERILE VIEW Barrier Sleeves combine superior protection against contaminants with unsurpassed comfort and the convenience of universal sizing....
Medicine Products: